January - March 2010, Volume 6, Issue 1

Gluhovschi G, Velciov S, Lazar E, Potencz E, Puscasiu T, Trandafirescu V, Petrica L, Bozdog G, Gluhovschi C, Bob F, Gadalean F, Lazar D

Retroperitoneal fibrosis with favorable evolution under treatment with tamoxifen

Acta Endo (Buc) 2010, 6 (1): 95-102
doi: 10.4183/aeb.2010.95

Retroperitoneal fibrosis (RPF), a disease with a severe outcome due to the complications it causes, can be associated with the processes of atherosclerosis with a massive and extensive fibrosis. In this paper we present a patient with retroperitoneal fibrosis in which we noticed estrogen receptors at the level of the periaortic fibrous tissue\r\nand we obtained a regression of this process under treatment with tamoxifen.

Keywords: selective estrogen receptor modulators, retroperitoneal fibrosis, tamoxifen

Correspondence: Gheorghe Gluhovschi MD, Timisoara, Romania Fax: +40256-486967,\r\nemail: ggluhovschi@yahoo.com